|
| |
JanusWe offer a broad range of investment options, but our expertise is in growth and risk-managed funds. Some of us are driven by a never-ending search for an information advantage. Others by an unwavering pursuit of a statistical advantage. Together, however, our goal is to deliver strong, long-term results to our shareholders. Learn more about us and how we invest.
| Contact Details: |
| P.O. Box 173375 |
| Denver |
| Colorado |
| 80217-3375 |
| United States of America |
| Tel: | 800.525.3713 |
| Fax: | |
| Email: | |
| WWW: | www.JANUS.COM/
|
|
Loading...
|
Recent Publications by Janus: |  |
[Description of erlotinib-related skin effects management in France. Results of the PRECEDE study]
INTRODUCTION: Dermatological effects are among the most frequent... | 29th May, 2009
| ICAR-service de nephrologie, hopital Pitie-Salpetriere, 83, boulevard de
| Cancer Radiother. 2009 Apr;13(2):97-102. Epub 2009 Feb 25.
DOI Direct Link |
New diagnostic and information technology for mobile medical care.
Medicare reimbursement for home visits average around $100 without... | 15th May, 2009
| Janus Health, 5030 Camino de la Siesta, San Diego, CA 92108, USA.
| Clin Geriatr Med. 2009 Feb;25(1):93-107, vii.
DOI Direct Link |
Identification of a minimal cre1 promoter sequence promoting glucose-dependent gene expression in the beta-lactam producer Acremonium chrysogenum.
The promoter of the cre1 gene, encoding the glucose-dependent regulator... | 20th June, 2008
| Lehrstuhl fur Allgemeine und Molekulare Botanik, Ruhr-Universitat,
| Curr Genet. 2008 Jan;53(1):35-48. Epub 2007 Nov 27.
DOI Direct Link |
Conditionally inducible tau mice--designing a better mouse model of neurodegenerative diseases.
Neuronal cell death underlies the majority of age-related human... | 13th March, 2008
| Department of Neuroscience, Mayo Clinic Jacksonville, Jacksonville, FL
| Genes Brain Behav. 2008 Feb;7 Suppl 1:12-27.
DOI Direct Link |
[Pharmacokinetics of amprenavir in HIV-1 patients with renal insufficiency]
Amprenavir is an HIV-1 protease inhibitor which is hepatically metabolized... | 26th February, 2008
| ICAR-Service de nephrologie, groupe hospitalier de la Pitie-Salpetriere,
| Med Mal Infect. 2007 Dec;37(12):832-4. Epub 2007 Nov 7.
DOI Direct Link |
→View more Janus research publications. |
Press Releases on Janus:
|
 |
| Cephalon Provides Clinical Update on Lestaurtinib in Relapsed Acute Myelogenous Leukemia |
19th June, 2009 |
Cephalon, Inc. |
FRAZER, Pa., June 19 /PRNewswire-FirstCall/ -- Cephalon, Inc. (Nasdaq: CEPH) today announced results from a pivotal clinical trial of lestaurtinib (CEP-701) in patients with relapsed acute
|
| Onyx Pharmaceuticals Acquires Option to License Novel Highly Specific JAK2 Inhibitors From S*BIO |
6th January, 2009 |
Onyx Pharmaceuticals, Inc. |
EMERYVILLE, Calif., Jan. 6 /PRNewswire-FirstCall/ -- Onyx Pharmaceuticals, Inc. (Nasdaq: ONXX) today announced that it has acquired an option to license rights to SB1518, an orally available, potent,
|
BioPortfolio Ltd provides targeted e-mail address lists for the life science sector - we can enable you to contact around 27 individuals from Janus using this service.  Contact BioPortfolio for a quote for a customised Excel verision of BioCorporate or BioEmail databases.
This page has been viewed 423 times since April 2007, the link to the organisation's website has been followed 42 times Recent Search Terms used to find this page: caminos janus | janus health | janus health | websdm 3.0 | which companies are promoting tofisopam | denny fisher janus | dennis fisher biocentric energy june 2009 | New Diagnostic and Information Technology for Mobile Medical Care | . Search for more companies in Denver Search for more companies in Colorado This site uses Thumbshots previews, resources from the NCBI applied. Maps are centred on zip/postcodes and should not be relied upon for exact building locations. Some information on this page has been collected automatically and may not have been verified.BioPortfolio search results for Janus |
